Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (302K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (40)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Faruqi, A. F.
Right arrow Articles by Glazer, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faruqi, A. F.
Right arrow Articles by Glazer, P. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 25, Issue 3 633-640, Copyright © 1997 by Oxford University Press


ARTICLES

Potassium-resistant triple helix formation and improved intracellular gene targeting by oligodeoxyribonucleotides containing 7-deazaxanthine

AF Faruqi, SH Krawczyk, MD Matteucci and PM Glazer
Department of Therapeutic Radiology, Yale University School of Medicine, PO Box 208040, New Haven, CT 06520-8040, USA.

Triple helix formation by purine-rich oligonucleotides in the anti- parallel motif is inhibited by physiological concentrations of potassium. Substitution with 7-deazaxanthine (c7X) has been suggested as a strategy to overcome this effect. We have tested this by examining triple helix formation both in vitro and in vivo by a series of triple helix-forming oligonucleotides (TFOs) containing guanine plus either adenine, thymine, or c7X. The TFOs were conjugated to psoralen at the 5'end and were designed to bind to a portion of the supF mutation reporter gene. Using in vitro gel mobility shift assays, we found that triplex formation by the c7X-substituted TFOs was relatively resistant to the presence of 140 mM K+. The c7X-containing TFOs were also superior in gene targeting experiments in mammalian cells, yielding 4- to 5-fold higher mutation frequencies in a shuttle vector-based mutagenesis assay designed to detect mutations induced by third strand- directed psoralen adducts. When the phosphodiester backbone was replaced by a phosphorothioate one, the in vitro binding of the c7X- TFOs was not affected, but the efficiency of in vivo triple helix formation was reduced. These results indicate the utility of the c7X substitution for in vivo gene targeting experiments, and they show that the feasibility of the triplex anti-gene strategy can be significantly enhanced by advances in nucleotide chemistry.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
F. A. Rogers, M. Manoharan, P. Rabinovitch, D. C. Ward, and P. M. Glazer
Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides
Nucleic Acids Res., December 15, 2004; 32(22): 6595 - 6604.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. J. Datta and P. M. Glazer
Intracellular generation of single-stranded DNA for chromosomal triplex formation and induced recombination
Nucleic Acids Res., December 15, 2001; 29(24): 5140 - 5147.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Basye, J. O. Trent, D. Gao, and S. W. Ebbinghaus
Triplex formation by morpholino oligodeoxyribonucleotides in the HER-2/neu promoter requires the pyrimidine motif
Nucleic Acids Res., December 1, 2001; 29(23): 4873 - 4880.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. DIVIACCO, V. RAPOZZI, L. XODO, C. HELENE, F. QUADRIFOGLIO, and C. GIOVANNANGELI
Site-directed inhibition of DNA replication by triple helix formation
FASEB J, December 1, 2001; 15(14): 2660 - 2668.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Vasquez, J. M. Dagle, D. L. Weeks, and P. M. Glazer
Chromosome Targeting at Short Polypurine Sites by Cationic Triplex-forming Oligonucleotides
J. Biol. Chem., October 12, 2001; 276(42): 38536 - 38541.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. P. Knauert and P. M. Glazer
Triplex forming oligonucleotides: sequence-specific tools for gene targeting
Hum. Mol. Genet., October 1, 2001; 10(20): 2243 - 2251.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Faria, C. D. Wood, L. Perrouault, J. S. Nelson, A. Winter, M. R. H. White, C. Helene, and C. Giovannangeli
Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides
PNAS, April 11, 2000; 97(8): 3862 - 3867.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. F. Faruqi, H. J. Datta, D. Carroll, M. M. Seidman, and P. M. Glazer
Triple-Helix Formation Induces Recombination in Mammalian Cells via a Nucleotide Excision Repair-Dependent Pathway
Mol. Cell. Biol., February 1, 2000; 20(3): 990 - 1000.
[Abstract] [Full Text]


Home page
BloodHome page
A. M. Gewirtz, D. L. Sokol, and M. Z. Ratajczak
Nucleic Acid Therapeutics: State of the Art and Future Prospects
Blood, August 1, 1998; 92(3): 712 - 736.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. F. Faruqi, M. Egholm, and P. M. Glazer
Peptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells
PNAS, February 17, 1998; 95(4): 1398 - 1403.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F.-L. M. Lin, A. Majumdar, L. C. Klotz, A. P. Reszka, S. Neidle, and M. M. Seidman
Stability of DNA Triplexes on Shuttle Vector Plasmids in the Replication Pool in Mammalian Cells
J. Biol. Chem., December 8, 2000; 275(50): 39117 - 39124.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.